Last update 15 May 2025

Docetaxel Liposomal(Intas Pharmaceuticals)

Overview

Basic Info

Drug Type
Small molecule drug, Liposomal Drug
Synonyms
NDLS, DoceAqualip
Target
Action
inhibitors
Mechanism
Tubulin inhibitors, Cells inhibitors, Mitosis inhibitors
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
Regulation-
Login to view timeline

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Advanced Gastric Adenocarcinoma
India
01 Jan 2013
Breast Cancer
India
01 Jan 2013
Castration-Resistant Prostatic Cancer
India
01 Jan 2013
Non-Small Cell Lung Cancer
India
01 Jan 2013
Squamous Cell Carcinoma of Head and Neck
India
01 Jan 2013
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Locally advanced breast cancerPhase 3
United States
10 Jul 2018
Locally advanced breast cancerPhase 3
India
10 Jul 2018
Triple Negative Breast CancerPhase 3
United States
10 Jul 2018
Triple Negative Breast CancerPhase 3
India
10 Jul 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
86
qkzqnetwch(dghkdxcpqf) = ivohrojadu zcsvlyjgir (txkggsvapo, 9.31 - 27.14)
Positive
13 Feb 2025
Phase 3
495
oprlcpoain(qpidsudwyk) = Use of NDLS led to a significant decrease in the incidence of mucositis mfmsivntfl (skgbnivpzy )
-
22 Oct 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free